CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Daré Bioscience, Inc. - DARE CFD

    0.2861
    9.52%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.0056
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 0.3162
    Open* 0.3182
    1-Year Change* -64.14%
    Day's Range* 0.2857 - 0.3184
    52 wk Range 0.28-1.40
    Average Volume (10 days) 356.84K
    Average Volume (3 months) 5.16M
    Market Cap 33.39M
    P/E Ratio -100.00K
    Shares Outstanding 98.56M
    Revenue 1.00M
    EPS -0.48
    Dividend (Yield %) N/A
    Beta 1.13
    Next Earnings Date Mar 28, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 7, 2023 0.3162 -0.0450 -12.46% 0.3612 0.3612 0.3068
    Dec 6, 2023 0.3402 -0.0151 -4.25% 0.3553 0.3553 0.3382
    Dec 5, 2023 0.3480 -0.0102 -2.85% 0.3582 0.3592 0.3447
    Dec 4, 2023 0.3582 0.0040 1.13% 0.3542 0.3881 0.3482
    Dec 1, 2023 0.3481 0.0025 0.72% 0.3456 0.3559 0.3387
    Nov 30, 2023 0.3467 -0.0016 -0.46% 0.3483 0.3533 0.3412
    Nov 29, 2023 0.3483 0.0063 1.84% 0.3420 0.3555 0.3332
    Nov 28, 2023 0.3402 0.0020 0.59% 0.3382 0.3484 0.3328
    Nov 27, 2023 0.3441 -0.0042 -1.21% 0.3483 0.3620 0.3312
    Nov 24, 2023 0.3435 0.0203 6.28% 0.3232 0.3537 0.3232
    Nov 22, 2023 0.3301 0.0018 0.55% 0.3283 0.3360 0.3277
    Nov 21, 2023 0.3370 -0.0012 -0.35% 0.3382 0.3423 0.3232
    Nov 20, 2023 0.3383 0.0071 2.14% 0.3312 0.3592 0.3312
    Nov 17, 2023 0.3340 0.0008 0.24% 0.3332 0.3532 0.3150
    Nov 16, 2023 0.3272 -0.0110 -3.25% 0.3382 0.3439 0.3232
    Nov 15, 2023 0.3382 -0.0100 -2.87% 0.3482 0.3522 0.3337
    Nov 14, 2023 0.3406 0.0097 2.93% 0.3309 0.3437 0.3249
    Nov 13, 2023 0.3333 0.0251 8.14% 0.3082 0.3623 0.2992
    Nov 10, 2023 0.3232 -0.0150 -4.44% 0.3382 0.3458 0.3232
    Nov 9, 2023 0.3182 -0.0411 -11.44% 0.3593 0.3693 0.3182

    Daré Bioscience, Inc. Events

    Time (UTC) Country Event
    Thursday, March 28, 2024

    Time (UTC)

    12:30

    Country

    US

    Event

    Q4 2023 Dare Bioscience Inc Earnings Release
    Q4 2023 Dare Bioscience Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 10 0 0 0 0
    Total Operating Expense 41.3855 38.6986 27.4023 14.3449 16.8823
    Selling/General/Admin. Expenses, Total 11.3433 8.45095 6.63284 5.79877 5.28084
    Research & Development 30.0422 30.6176 20.7694 8.54611 6.41396
    Unusual Expense (Income) 0 -0.36989 0 5.18752
    Operating Income -31.3855 -38.6986 -27.4023 -14.3449 -16.8823
    Interest Income (Expense), Net Non-Operating
    Net Income Before Taxes -30.9477 -38.6961 -27.4007 -14.2638 -16.7388
    Net Income After Taxes -30.9477 -38.6961 -27.4007 -14.2638 -16.7388
    Net Income Before Extra. Items -30.9477 -38.6961 -27.4007 -14.2638 -16.7388
    Net Income -30.9477 -38.6961 -27.4007 -14.2638 -16.7388
    Income Available to Common Excl. Extra. Items -30.9477 -38.6961 -27.4076 -15.0534 -16.7388
    Income Available to Common Incl. Extra. Items -30.9477 -38.6961 -27.4076 -15.0534 -16.7388
    Diluted Net Income -30.9477 -38.6961 -27.4076 -15.0534 -16.7388
    Diluted Weighted Average Shares 84.5718 61.1542 30.0915 15.579 10.7324
    Diluted EPS Excluding Extraordinary Items -0.36593 -0.63276 -0.91081 -0.96627 -1.55965
    Diluted Normalized EPS -0.36593 -0.63881 -0.91081 -0.96627 -1.0763
    Total Extraordinary Items
    Other, Net 0.43775 0.00252 0.00151 0.08105 0.1435
    Total Adjustments to Net Income 0 -0.00686 -0.78959
    Revenue 10
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 0 0 0 0 10
    Total Operating Expense 8.98936 8.38265 16.2306 7.13879 9.61568
    Selling/General/Admin. Expenses, Total 2.94567 3.36243 3.25385 2.67654 2.81789
    Research & Development 6.04368 5.02022 12.9767 4.46225 6.79778
    Unusual Expense (Income) 0 0 0
    Operating Income -8.98936 -8.38265 -16.2306 -7.13879 0.38432
    Other, Net 0.22712 0.34015 0.28734 0.11895 0.02968
    Net Income Before Taxes -8.76223 -8.0425 -15.9432 -7.01984 0.414
    Net Income After Taxes -8.76223 -8.0425 -15.9432 -7.01984 0.414
    Net Income Before Extra. Items -8.76223 -8.0425 -15.9432 -7.01984 0.414
    Net Income -8.76223 -8.0425 -15.9432 -7.01984 0.414
    Income Available to Common Excl. Extra. Items -8.76223 -8.0425 -15.9432 -7.01984 0.414
    Income Available to Common Incl. Extra. Items -8.76223 -8.0425 -15.9432 -7.01984 0.414
    Diluted Net Income -8.76223 -8.0425 -15.9432 -7.01984 0.414
    Diluted Weighted Average Shares 86.4031 85.5175 81.6278 84.8225 85.3694
    Diluted EPS Excluding Extraordinary Items -0.10141 -0.09405 -0.19532 -0.08276 0.00485
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.10141 -0.09405 -0.19532 -0.08276 0.00485
    Total Adjustments to Net Income
    Revenue 0 0 0 10
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 43.0387 55.296 6.98391 6.44393 7.24002
    Cash and Short Term Investments 34.6696 51.6741 4.66947 4.78011 6.80589
    Cash & Equivalents 34.6696 51.6741 4.66947 4.78011 6.80589
    Total Assets 43.8264 55.8072 7.55071 7.44279 7.82739
    Total Current Liabilities 31.6239 16.0529 7.6606 5.61241 1.09106
    Payable/Accrued
    Accrued Expenses 11.2924 3.40679 3.70743 2.50955 0.63135
    Notes Payable/Short Term Debt 0 0 0.36729 0 0
    Total Liabilities 32.7143 17.0529 8.70245 7.00196 1.10077
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 1.09035 1 1.04184 1.38956 0.00971
    Total Equity 11.1121 38.7543 -1.15173 0.44083 6.72662
    Redeemable Preferred Stock 0 0 0 0 0
    Common Stock 0.00848 0.00839 0.00416 0.00197 0.00114
    Additional Paid-In Capital 152.53 149.028 70.3663 44.5647 35.792
    Retained Earnings (Accumulated Deficit) -141.075 -110.127 -71.4308 -44.0232 -28.9698
    Total Liabilities & Shareholders’ Equity 43.8264 55.8072 7.55071 7.44279 7.82739
    Total Common Shares Outstanding 84.8255 83.9441 41.5962 19.6834 11.4222
    Total Receivables, Net 1.70316 1.14532 0.46017 0.55521 0.03104
    Prepaid Expenses 6.66599 2.47661 1.85428 1.10862 0.4031
    Other Current Assets, Total 0
    Goodwill, Net 0
    Other Long Term Assets, Total 0.2648 0.26845 0.28932 0.44733 0.57797
    Other Equity, Total -0.35131 -0.15497 -0.09139 -0.10263 -0.09673
    Property/Plant/Equipment, Total - Net 0.52283 0.24271 0.27748 0.55153 0.0094
    Accounts Payable 2.02795 2.10308 1.02133 1.08318 0.45971
    Other Current Liabilities, Total 18.3036 10.543 2.56455 2.01967
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 22.4355 22.2433 29.5119 43.0387 49.5671
    Cash and Short Term Investments 13.8944 13.3291 19.8294 34.6696 40.3895
    Cash & Equivalents 13.8944 13.3291 19.8294 34.6696 40.3895
    Total Receivables, Net 1.12976 0.57247 2.39871 1.70316 2.29204
    Prepaid Expenses 6.57993 8.06962 7.08245 6.66599 6.8855
    Total Assets 25.054 23.2099 30.3667 43.8264 50.3764
    Property/Plant/Equipment, Total - Net 0.24062 0.32179 0.4234 0.52283 0.61883
    Other Long Term Assets, Total 2.37791 0.64488 0.43133 0.2648 0.19051
    Total Current Liabilities 26.3428 24.7008 24.3379 31.6239 22.8381
    Accounts Payable 4.9874 6.54112 2.69561 2.02795 3.47719
    Accrued Expenses 5.48783 4.46562 5.81597 11.2924 4.52447
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 15.8675 13.6941 15.8264 18.3036 14.8364
    Total Liabilities 27.3428 25.9294 25.3951 32.7143 24.0327
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 1 1.22853 1.05713 1.09035 1.19459
    Total Equity -2.28874 -2.7194 4.9716 11.1121 26.3438
    Redeemable Preferred Stock 0 0 0 0 0
    Common Stock 0.00983 0.00866 0.00862 0.00848 0.00848
    Additional Paid-In Capital 164.299 155.556 154.453 152.53 151.997
    Retained Earnings (Accumulated Deficit) -166.178 -157.879 -149.117 -141.075 -125.131
    Other Equity, Total -0.4195 -0.40447 -0.37332 -0.35131 -0.53074
    Total Liabilities & Shareholders’ Equity 25.054 23.2099 30.3667 43.8264 50.3764
    Total Common Shares Outstanding 98.2923 86.6336 86.179 84.8255 84.8255
    Accounts Receivable - Trade, Net
    Other Current Assets, Total 0.83138 0.2721 0.20139
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -30.9477 -38.6961 -27.4007 -14.2638 -16.7388
    Cash From Operating Activities -18.0884 -28.764 -25.2349 -13.3155 -10.2684
    Non-Cash Items 2.13545 1.17796 0.57986 0.26014 5.83387
    Cash Taxes Paid 0
    Changes in Working Capital 10.6997 8.7277 1.54273 0.67707 0.63408
    Cash From Investing Activities -0.06307 -0.01452 -0.01763 6.14389 -0.51884
    Other Investing Cash Flow Items, Total 0 6.14389 -0.507
    Cash From Financing Activities 1.34335 75.8468 25.1307 5.1517 10.1119
    Issuance (Retirement) of Debt, Net 0 0.36729 0
    Foreign Exchange Effects -0.19634 -0.06359 0.01124 -0.0059 -0.07865
    Net Change in Cash -17.0045 47.0046 -0.11064 -2.02578 -0.75396
    Cash Interest Paid 0
    Cash From Operating Activities 0.0242 0.02641 0.04323 0.01114 0.00244
    Capital Expenditures -0.06307 -0.01452 -0.01763 0 -0.01184
    Issuance (Retirement) of Stock, Net 1.34335 75.8468 24.7634 5.1517 10.1119
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -8.0425 -30.9477 -15.0045 -7.98467 -8.39867
    Cash From Operating Activities -16.1176 -18.0884 -12.1918 -20.792 -12.3435
    Cash From Operating Activities 0.00951 0.0242 0.01358 0.01055 0.00523
    Non-Cash Items 0.61872 2.13545 1.60922 1.07987 0.52265
    Changes in Working Capital -8.70329 10.6997 1.18996 -13.8977 -4.47268
    Cash From Financing Activities 1.29938 1.34335 1.34336 1.3389 0
    Issuance (Retirement) of Stock, Net 1.29938 1.34335 1.34336 1.3389 0
    Foreign Exchange Effects -0.02201 -0.19634 -0.37577 -0.14502 -0.00915
    Net Change in Cash -14.8402 -17.0045 -11.2845 -19.6035 -12.3572
    Cash From Investing Activities 0 -0.06307 -0.06037 -0.00537 -0.00455
    Capital Expenditures 0 -0.06307 -0.06037 -0.00537 -0.00455
    Issuance (Retirement) of Debt, Net
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.5045 3444675 -15545 2023-06-30 LOW
    Johnson (Sabrina Martucci) Individual Investor 0.9788 962062 0 2023-04-07 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.8315 817336 0 2023-06-30 LOW
    Renaissance Technologies LLC Hedge Fund 0.7313 718821 149762 2023-06-30 HIGH
    Walters-Hoffert (Lisa) Individual Investor 0.4512 443512 0 2023-04-07 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.4054 398457 -210486 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.252 247710 0 2023-06-30 LOW
    Steele Robin Joan Individual Investor 0.2504 246171 0 2023-04-07 LOW
    Susquehanna International Group, LLP Investment Advisor 0.1669 164021 164021 2023-06-30 MED
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1641 161316 -352 2023-06-30 LOW
    T. Rowe Price International Ltd Investment Advisor/Hedge Fund 0.1281 125900 0 2023-06-30 LOW
    Founders Financial Securities, LLC Investment Advisor 0.1262 124000 10000 2023-09-30 MED
    InterWest Partners Venture Capital 0.0631 62065 0 2023-09-30 LOW
    Citadel Advisors LLC Hedge Fund 0.0508 49901 -194740 2023-06-30 LOW
    Commonwealth Financial Network Investment Advisor 0.0502 49329 -250 2023-09-30 LOW
    Charles Schwab Investment Management, Inc. Investment Advisor 0.0311 30532 0 2023-06-30 LOW
    BNY Mellon Asset Management Investment Advisor 0.0233 22947 0 2023-09-30 LOW
    Raymond James Financial Services Advisors, Inc. Investment Advisor 0.0203 20000 -10 2023-09-30 LOW
    Advisory Services Network, LLC Investment Advisor 0.0153 15000 0 2023-06-30 LOW
    Lord, Abbett & Co. LLC Investment Advisor 0.0151 14808 0 2023-07-31 MED

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Daré Bioscience, Inc. Company profile

    Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing products for women''s health in the United States. The company develops therapies in the areas of contraception, fertility, and sexual and vaginal health. Its products in advanced clinical development include DARE-BV1, a bioadhesive hydrogel formulated with clindamycin phosphate 2% to treat bacterial vaginosis in a single administration that has completed Phase 3 clinical trials; Ovaprene, a hormone-free monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company''s Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ORB-204 and ORB-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women. The company is headquartered in San Diego, California.
    Industry: Biotechnology & Medical Research (NEC)

    3655 Nobel Dr Ste 260
    SAN DIEGO
    CALIFORNIA 92122-1050
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    BTC/USD

    44,252.10 Price
    +2.010% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Oil - Crude

    71.41 Price
    +2.320% 1D Chg, %
    Long position overnight fee -0.0204%
    Short position overnight fee -0.0015%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    XRP/USD

    0.68 Price
    +4.560% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    US100

    16,080.90 Price
    +0.500% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading